Revelation Alpine, LLC - 09 Jun 2025 Form 4 Insider Report for Omada Health, Inc. (OMDA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 Jun 2025, 17:22:16 UTC
Prior SEC filing
05 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
REVELATION ALPINE, LLC, By: /s/ Michael Boggs, Managing Member of Manager

Key filing fact

Revelation Alpine, LLC filed Form 4 for Omada Health, Inc. (OMDA) on 09 Jun 2025.

Key facts

  • This page summarizes Revelation Alpine, LLC's Form 4 filing for Omada Health, Inc. (OMDA).
  • 11 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 09 Jun 2025, 17:22.

Change

  • Previous filing in this sequence was filed on 05 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (3)

CIK 0001910436 Primary reporting owner

Revelation Alpine, LLC

Relationship
10%+ Owner
Address
300 TURNEY STREET, 2ND FLOOR, SAUSALITO
Signature
REVELATION ALPINE, LLC, By: /s/ Michael Boggs, Managing Member of Manager
Signature date
09 Jun 2025
CIK 0002070450

Boggs Michael Huff

Relationship
10%+ Owner
Address
300 TURNEY STREET, 2ND FLOOR, SAUSALITO
Signature
/s/ Michael Boggs
Signature date
09 Jun 2025
CIK 0001204322

HALSTED SCOTT S

Relationship
10%+ Owner
Address
300 TURNEY STREET, 2ND FLOOR, SAUSALITO
Signature
/s/ Scott S. Halsted
Signature date
09 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMDA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+469,222
Change %
+1983%
Price
Shares after
492,886
Date
09 Jun 2025
Ownership
See footnotes
Footnotes
F1, F2, F6, F7
OMDA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+456,184
Change %
+132%
Price
Shares after
802,849
Date
09 Jun 2025
Ownership
See footnotes
Footnotes
F1, F3, F6, F7
OMDA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+2,439,265
Change %
+372%
Price
Shares after
3,095,306
Date
09 Jun 2025
Ownership
See footnotes
Footnotes
F1, F4, F6, F7
OMDA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+816,993
Change %
Price
Shares after
816,993
Date
09 Jun 2025
Ownership
See footnotes
Footnotes
F1, F5, F6, F7

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OMDA transaction Derivative

Series C Preferred Stock

Conversion of derivative security

Transaction value
Shares
-158,072
Change %
-100%
Price
Shares after
0
Date
09 Jun 2025
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
158,072
Exercise price
Footnotes
F1, F2, F6, F7
OMDA transaction Derivative

Series C-1 Preferred Stock

Conversion of derivative security

Transaction value
Shares
-44,535
Change %
-100%
Price
Shares after
0
Date
09 Jun 2025
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
44,535
Exercise price
Footnotes
F1, F2, F6, F7
OMDA transaction Derivative

Series E Preferred Stock

Conversion of derivative security

Transaction value
Shares
-266,615
Change %
-100%
Price
Shares after
0
Date
09 Jun 2025
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
266,615
Exercise price
Footnotes
F1, F2, F6, F7
OMDA transaction Derivative

Series E Preferred Stock

Conversion of derivative security

Transaction value
Shares
-456,184
Change %
-100%
Price
Shares after
0
Date
09 Jun 2025
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
456,184
Exercise price
Footnotes
F1, F3, F6, F7
OMDA transaction Derivative

Series D Preferred Stock

Conversion of derivative security

Transaction value
Shares
-2,161,265
Change %
-100%
Price
Shares after
0
Date
09 Jun 2025
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
2,161,265
Exercise price
Footnotes
F1, F4, F6, F7
OMDA transaction Derivative

Series E Preferred Stock

Conversion of derivative security

Transaction value
Shares
-278,000
Change %
-100%
Price
Shares after
0
Date
09 Jun 2025
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
278,000
Exercise price
Footnotes
F1, F4, F6, F7
OMDA transaction Derivative

Series D Preferred Stock

Conversion of derivative security

Transaction value
Shares
-816,993
Change %
-100%
Price
Shares after
0
Date
09 Jun 2025
Ownership
See footnotes
Underlying class
Common Stock
Underlying amount
816,993
Exercise price
Footnotes
F1, F5, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Revelation Alpine, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 7 footnotes

Footnote F1

Each share of Series C Preferred Stock, Series C-1 Preferred Stock, Series D Preferred Stock and Series E Preferred Stock automatically converted into approximately 0.33333 shares of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted basis and have no expiration date.

Footnote F2

Shares held by Revelation Alpine, LLC.

Footnote F3

Shares held by Revelation Healthcare Fund II, L.P.

Footnote F4

Shares held by Revelation Healthcare Fund IV, L.P.

Footnote F5

Shares held by Revelation Alpine, L.P.

Footnote F6

Revelation Healthcare Fund II GP, LLC is the general partner of Revelation Healthcare Fund II GP, L.P., which is the general partner of Revelation Healthcare Fund II, L.P. Revelation Alpine GP, LLC is the general partner of Revelation Alpine, L.P. and the manager of Revelation Alpine, LLC. Revelation Healthcare Fund IV GP, LLC is the general partner of Revelation Healthcare Fund IV GP, L.P., which is the general partner of Revelation Healthcare Fund IV, L.P. Scott Halsted and Michael Boggs are the managing members of Revelation Healthcare Fund II GP, LLC, Revelation Alpine GP, LLC, and Revelation Healthcare Fund IV GP, LLC and in such capacity make investment and voting decisions on behalf of Revelation Alpine, LLC, Revelation Healthcare Fund II, L.P., Revelation Healthcare Fund IV, L.P. and Revelation Alpine, L.P.

Footnote F7

Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act or for any other purpose.

SEC remarks

Form 2 of 2: This Form 4 is the second of two Forms 4 being filed relating to the same event. The Form 4 has been split into two filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 will be filed by Designated Filer Revelation Alpine, LLC.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .